Adjunct Clinical Assistant Professor of Radiation Oncology
[email protected]
Available to mentor
Caitlin Schonewolf
Adjunct Clinical Assistant Professor
-
Mazzone PJ, Bach PB, Carey J, Schonewolf CA, Bognar K, Ahluwalia MS, Cruz-Correa M, Gierada D, Kotagiri S, Lloyd K, Maldonado F, Ortendahl JD, Sequist LV, Silvestri GA, Tanner N, Thompson JC, Vachani A, Wong K-K, Zaidi AH, Catallini J, Gershman A, Lumbard K, Millberg LK, Nawrocki J, Portwood C, Rangnekar A, Sheridan CC, Trivedi N, Wu T, Zong Y, Cotton L, Ryan A, Cisar C, Leal A, Dracopoli N, Scharpf RB, Velculescu VE, Pike LRG. Cancer Discov, 2024 Nov 1; 14 (11): 2224 - 2242.Journal ArticleClinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection.
DOI:10.1158/2159-8290.CD-24-0519 PMID: 38829053 -
COTTON L, BACH P, CISAR C, TENNEFOSS D, SCHONEWOLF C, WILSON M, MAGNUSON C. CHEST Journal, 2024 Oct; 166 (4): a3972 - a3973.Journal ArticleIMPROVING THE EFFICIENCY OF LUNG CANCER SCREENING THROUGH THE USE OF A POINT-OF-CARE, BLOOD-BASED LUNG CANCER SCREENING TEST PRIOR TO LOW-DOSE CT SCAN
DOI:10.1016/j.chest.2024.06.2403 -
Cotton L, Bach P, Kazerooni E, Cisar C, Tennefoss D, Schonewolf C, Wilson M, Magnuson C. Journal of Thoracic Oncology, 2024 Oct; 19 (10): s368 - s369.Journal ArticleP4.04C.07 Improving the Efficiency of Lung Cancer Screening Through a Blood-based Lung Cancer Screening Test Prior to Low-Dose CT
DOI:10.1016/j.jtho.2024.09.664 -
Cotton LB, Bach PB, Cisar C, Schonewolf CA, Tennefoss D, Vachani A, Carter-Bawa L, Zaidi AH. J Clin Med, 2024 Aug 20; 13 (16):Journal ArticleInnovations in Early Lung Cancer Detection: Tracing the Evolution and Advancements in Screening.
DOI:10.3390/jcm13164911 PMID: 39201053 -
Cotton LB, Ortendahl J, Bognar K, Bach PB, Schonewolf C, Tennefoss D, Cisar C. 2024 May; a7305 - a7305.Proceeding / Abstract / PosterImproved Lung Cancer Screening Outcomes Through Blood-Based Genomic Testing: Population and Payer Impact
DOI:10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7305 -
Journal of the National Comprehensive Cancer Network : JNCCN, 2024 Apr 5; 22 (25):Journal ArticleHSR24-171: Utilizing Diverse Enrollment to Validate the DELFI Fragmentome Test for Advancing Lung Cancer Screening
DOI:10.6004/jnccn.2023.7257 -
Mazzone P, Bach PB, Cotton LB, Schonewolf CA. Cancer Research, 2024 Mar 22; 84 (6_Supplement): 1062 - 1062.Journal ArticleAbstract 1062: Clinical validation: A blood-based biomarker for early lung cancer detection based on circulating DNA fragmentomics
DOI:10.1158/1538-7445.am2024-1062 -
Edwards DM, Schonewolf CA, Rice JD, Schipper M, Haken RKT, Matuszak M, Balter J, Jarema D, Arenberg DA, Piert M, Qin A, Kalemkerian GP, Schneider BJ, Ramnath N, Chapman CH, Elliott DA, Lawrence TS, Hearn J, Hayman JA, Jolly S. Int J Radiat Oncol Biol Phys, 2024 Jul 4;Journal ArticlePhase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung Cancer.
DOI:10.1016/j.ijrobp.2024.06.018 PMID: 38971385